Anna Flender

711 total citations
9 papers, 573 citations indexed

About

Anna Flender is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Anna Flender has authored 9 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Immunology. Recurrent topics in Anna Flender's work include Extracellular vesicles in disease (5 papers), MicroRNA in disease regulation (5 papers) and Circular RNAs in diseases (3 papers). Anna Flender is often cited by papers focused on Extracellular vesicles in disease (5 papers), MicroRNA in disease regulation (5 papers) and Circular RNAs in diseases (3 papers). Anna Flender collaborates with scholars based in Germany and United States. Anna Flender's co-authors include Georg Nickenig, Felix Jansen, Theresa Schmitz, Nikos Werner, Xiaoyan Yang, Philipp Pfeifer, Bernardo S. Franklin, Andreas Zietzer, Philip Roger Goody and Han Wang and has published in prestigious journals such as Circulation Research, Journal of Molecular and Cellular Cardiology and Journal of Cellular and Molecular Medicine.

In The Last Decade

Anna Flender

9 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Flender Germany	9	461	322	134	124	42	9	573
Mark Roufaiel Canada	5	252 0.5×	154 0.5×	73 0.5×	132 1.1×	60 1.4×	7	411
Karina Di Gregoli United Kingdom	7	224 0.5×	259 0.8×	69 0.5×	149 1.2×	50 1.2×	9	435
Hengxun Hu China	4	456 1.0×	260 0.8×	84 0.6×	51 0.4×	99 2.4×	6	581
Hendrika A. B. Peters Netherlands	13	246 0.5×	119 0.4×	56 0.4×	151 1.2×	75 1.8×	27	502
Daniel Lightell United States	10	281 0.6×	219 0.7×	67 0.5×	56 0.5×	70 1.7×	12	404
Yuliya Ponomareva Germany	7	758 1.6×	790 2.5×	98 0.7×	52 0.4×	43 1.0×	8	948
A.J.N.M. Bastiaansen Netherlands	10	282 0.6×	121 0.4×	27 0.2×	105 0.8×	118 2.8×	11	433
Vicken W. Chan Hong Kong	8	266 0.6×	129 0.4×	81 0.6×	116 0.9×	131 3.1×	8	497
Liang Du United States	11	152 0.3×	109 0.3×	65 0.5×	99 0.8×	86 2.0×	17	409
Zhi‐Ru Ge China	8	235 0.5×	134 0.4×	76 0.6×	38 0.3×	63 1.5×	13	356

Countries citing papers authored by Anna Flender

Since Specialization

Citations

This map shows the geographic impact of Anna Flender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Flender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Flender more than expected).

Fields of papers citing papers by Anna Flender

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Flender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Flender. The network helps show where Anna Flender may publish in the future.

Co-authorship network of co-authors of Anna Flender

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Flender. A scholar is included among the top collaborators of Anna Flender based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Flender. Anna Flender is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Lüsebrink, Enzo, Philip Roger Goody, Catharina Lahrmann, et al.. (2020). AIM2 Stimulation Impairs Reendothelialization and Promotes the Development of Atherosclerosis in Mice. Frontiers in Cardiovascular Medicine. 7. 582482–582482. 23 indexed citations

Lüsebrink, Enzo, et al.. (2020). Toll-Like Receptor 7 Stimulation Promotes the Development of Atherosclerosis in Apolipoprotein E-Deficient Mice. International Heart Journal. 61(2). 364–372. 11 indexed citations

Liu, Yang, Qian Li, Mohammed Rabiul Hosen, et al.. (2019). Atherosclerotic Conditions Promote the Packaging of Functional MicroRNA-92a-3p Into Endothelial Microvesicles. Circulation Research. 124(4). 575–587. 140 indexed citations

Jansen, Felix, Bernardo S. Franklin, Daniela Wenzel, et al.. (2017). Intercellular transfer of miR-126-3p by endothelial microparticles reduces vascular smooth muscle cell proliferation and limits neointima formation by inhibiting LRP6. Journal of Molecular and Cellular Cardiology. 104. 43–52. 108 indexed citations

Jansen, Felix, Andreas Zietzer, Anna Flender, et al.. (2017). Endothelial microparticle-promoted inhibition of vascular remodeling is abrogated under hyperglycaemic conditions. Journal of Molecular and Cellular Cardiology. 112. 91–94. 18 indexed citations

Jansen, Felix, Han Wang, Theresa Schmitz, et al.. (2017). Kinetics of Circulating MicroRNAs in Response to Cardiac Stress in Patients With Coronary Artery Disease. Journal of the American Heart Association. 6(8). 30 indexed citations

Jansen, Felix, Han Wang, Bernardo S. Franklin, et al.. (2016). Vascular endothelial microparticles-incorporated microRNAs are altered in patients with diabetes mellitus. Cardiovascular Diabetology. 15(1). 49–49. 115 indexed citations

Steinmetz, Martin, Catharina Lahrmann, Anna Flender, et al.. (2016). MDA‐5 activation by cytoplasmic double‐stranded RNA impairs endothelial function and aggravates atherosclerosis. Journal of Cellular and Molecular Medicine. 20(9). 1696–1705. 19 indexed citations

Jansen, Felix, Xiaoyan Yang, Theresa Schmitz, et al.. (2015). Endothelial microparticles reduce ICAM‐1 expression in a microRNA‐222‐dependent mechanism. Journal of Cellular and Molecular Medicine. 19(9). 2202–2214. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact